| Non-Alcoholic Fatty Liver Disease |
1 |
1 |
| Biliary Disease |
0 |
0.9 |
| Metabolic Syndrome |
0 |
0.95 |
| Liver Disease |
0 |
0.75 |
| Liver |
0 |
0.69 |
| Fatty Liver |
0 |
0.67 |
| Hepatic Fibrosis |
0 |
0.67 |
| Cirrhosis |
0 |
0.32 |
| Preventive Screening |
0 |
0.99 |
| Obesity |
0 |
0.31 |
| Bariatric Surgery |
0 |
0.21 |
| Clinical Guidelines |
0 |
0.16 |
| Drug Development |
0 |
0.16 |
| Type 2 Diabetes Mellitus |
0 |
0.15 |
| Epidemic |
0 |
0.11 |
| Epidemiology |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Metabolism |
0 |
0.11 |
| Statins |
0 |
0.11 |
| Steatosis |
0 |
0.11 |
| Surgery |
0 |
0.11 |
| Lipids Management |
0 |
0.07 |
| Diet |
0 |
0.05 |
| DPP-4 Inhibitors |
0 |
0.05 |
| Multidisciplinary Team |
0 |
0.05 |
| Nonalcoholic Steatohepatitis |
0 |
0.05 |
| Pathogenesis |
0 |
0.05 |
| Primary Care |
0 |
0.05 |
| Vitamin |
0 |
0.05 |
| Weight Loss |
0 |
0.05 |
| Cardiovascular Risk Management |
0 |
0.04 |
| Weight Management |
0 |
0.04 |